Capstone Investment Advisors, LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
701
Total Value
26336722897
Accession Number
0001426196-25-000001
Form Type
13F-HR
Manager Name
Capstone Investment Advisors, LLC
Data Enrichment
82% identified
573 identified128 unidentified

Holdings

701 positions
Manager:
Search and click to pin securities to the top
Page 35 of 36
CITIZENS, INC.
Shares:
10184
Value:
$46.3M
Eledon Pharmaceuticals, Inc.
Shares:
13613
Value:
$46.1M
UNITED STATES ANTIMONY CORP
Shares:
18858
Value:
$41.5M
Corvus Pharmaceuticals, Inc.
Shares:
12644
Value:
$40.2M
Protalix BioTherapeutics, Inc.
Shares:
15336
Value:
$39.3M
Aclaris Therapeutics, Inc.
Shares:
23564
Value:
$36.1M
Expensify, Inc.
Shares:
11632
Value:
$35.4M
BLUE RIDGE BANKSHARES, INC.
Shares:
10478
Value:
$34.2M
Rezolute, Inc.
Shares:
11318
Value:
$32.8M
KOPIN CORP
Shares:
33867
Value:
$31.6M
SANGAMO THERAPEUTICS, INC
Shares:
45347
Value:
$29.7M
Vuzix Corp
Shares:
13879
Value:
$28.3M
Douglas Elliman Inc.
Shares:
16353
Value:
$28.1M
KULR Technology Group, Inc.
Shares:
19868
Value:
$26.2M
Inhibikase Therapeutics, Inc.
Shares:
11067
Value:
$24.2M
Alto Ingredients, Inc.
Shares:
16596
Value:
$18.9M
Origin Materials, Inc.
Shares:
26432
Value:
$17.5M
Ondas Holdings Inc.
Shares:
14510
Value:
$15.5M
PLBY Group, Inc.
Shares:
11533
Value:
$12.7M
BIODESIX INC
Shares:
15437
Value:
$9.7M